BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28577944)

  • 1. Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis.
    Boland JM; Wampfler JA; Yang P; Yi ES
    Lung Cancer; 2017 Jul; 109():14-20. PubMed ID: 28577944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
    Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
    J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma.
    Nakazato Y; Maeshima AM; Ishikawa Y; Yatabe Y; Fukuoka J; Yokose T; Tomita Y; Minami Y; Asamura H; Tachibana K; Goya T; Noguchi M
    J Thorac Oncol; 2013 Jun; 8(6):736-43. PubMed ID: 23676557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.
    Warth A; Muley T; Kossakowski C; Stenzinger A; Schirmacher P; Dienemann H; Weichert W
    J Thorac Oncol; 2015 Apr; 10(4):638-44. PubMed ID: 25634008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
    Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
    Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
    Hwang I; Park KU; Kwon KY
    Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
    Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
    Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.
    Xu L; Tavora F; Burke A
    Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
    Sica G; Yoshizawa A; Sima CS; Azzoli CG; Downey RJ; Rusch VW; Travis WD; Moreira AL
    Am J Surg Pathol; 2010 Aug; 34(8):1155-62. PubMed ID: 20551825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma.
    Moreira AL; Joubert P; Downey RJ; Rekhtman N
    Hum Pathol; 2014 Feb; 45(2):213-20. PubMed ID: 24439219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
    Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
    Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current readings: pathology, prognosis, and lung cancer.
    Suh JH
    Semin Thorac Cardiovasc Surg; 2013; 25(1):14-21. PubMed ID: 23800525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas?
    Nambirajan A; Kaur H; Jangra K; Kaur K; Madan K; Mathur SR; Iyer VK; Jain D
    Cytopathology; 2018 Apr; 29(2):163-171. PubMed ID: 29388266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
    J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
    Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
    Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.